Caribou Biosciences (CRBU) Treasury Shares (2020 - 2026)
Caribou Biosciences (CRBU) posted quarterly Treasury Shares of $3.0 million for Q1 2026, up 36.16% year-over-year from $2.2 million in Q1 2025, and up 38.95% quarter-over-quarter from $2.2 million in Q4 2025.
Caribou Biosciences (CRBU) Treasury Shares (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has reported Treasury Shares for 7 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares rose 36.16% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (up 36.16% YoY), while the FY2025 annual figure was $2.2 million, up 67.52% from the prior year.
- Treasury Shares improved to $3.0 million in Q1 2026 per CRBU's latest filing, from $2.2 million in the prior quarter.
- Across five years, Treasury Shares topped out at $3.0 million in Q1 2026 and bottomed at $60000.0 in Q1 2022.
- Historically, Treasury Shares has averaged $1.1 million across 5 years, with a median of $1.2 million in 2024.
- Annual changes were most pronounced in 2022 — Treasury Shares tumbled 99.58% — and 2024, when it surged 673.49%.
- Caribou Biosciences' Treasury Shares stood at $256146.0 in 2022, then slipped by 19.83% to $205357.0 in 2023, then jumped by 531.74% to $1.3 million in 2024, then soared by 67.52% to $2.2 million in 2025, then soared by 38.95% to $3.0 million in 2026.
- Business Quant data shows CRBU's Treasury Shares at $3.0 million in Q1 2026, $2.2 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Caribou Biosciences | 166.63 Mn | 54.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.90 Mn |
| Jun 30, 2026 | 2.90 Mn |
| Mar 31, 2026 | 3.02 Mn |
| Mar 31, 2026 | 3.02 Mn |
| Dec 31, 2025 | 2.17 Mn |
| Dec 31, 2025 | 2.17 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.18 Mn |